All In Biotech

Drug Trial Radar · NCT05916287

FAMILY INHERITANCE, GENE-GENE AND GENE-ENVIRONMENT INTERACTIONS IN THE FIELD OF CARDIOVASCULAR AND RENAL DISEASES. Fifth Visit of the STANISLAS Cohort

HÉRITABILITÉ FAMILIALE, INTERACTIONS GÈNE-GÈNE ET GÈNE-ENVIRONNEMENT DANS LE DOMAINE DES MALADIES CARDIOVASCULAIRES ET RENALES. Cinquième Visite de la Cohorte STANISLAS

Last checked: Nov 19, 2026Latest source record: Aug 15, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

3,000

Planned (sponsor's estimate)

Start

Jul 13, 2023

Primary completion

Jul 13, 2027

Study completion Jul 13, 2027

Sponsor

Lead sponsor
Central Hospital, Nancy, FranceAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jun 23, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Other
FDA-regulated drug
No
Who can join
All sexes
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The Stanislas Cohort is a monocentric familial longitudinal cohort originally comprised of 1006 families consisting of two parents and at least two biological children and deemed healthy, recruited in 1993-1995 at the Centre for Preventive Medicine of Nancy. This cohort was established with the primary objective of investigating gene-gene and gene-environment interactions in the field of cardiovascular diseases. The 5th visit of the STANISLAS Cohort will allow a better evaluation of the cardiovascular ageing of the population and the transition toward cardiovascular or renal diseases in relation with their genetic profile and environment.

Conditions

  • Cardiovascular Diseases
  • Cohort Studies
  • Genotype
  • Risk Factors
  • Nutrition

Interventions

  • Blood and urine samplesBiological

    Blood and urine samples

  • Blood samplesGenetic

    Blood samples

  • Cardiovascular assessmentOther

    Echocardiography, Lung ultrasound, pulse wave velocity, carotid stiffness and thickness, Central and peripheral blood pressure, carotid pulse pressure, abdominal aorta ultrasound, jugular vein ultrasound, liver elastography (Optional).

  • Dietary intakeBehavioral

    Food frequency questionnaires, ''Dutch eating behaviour questionnaire'' and dietary supplement questionnaire

  • Anthropometric parametersOther

    Measurement of height, weight, abdominal circumference, hip circumference, arm circumference

  • Hemodynamic parametersOther

    Systolic pressure index measurement

  • Hemodynamic parametersOther

    Heart rate measurements, blood pressure measurements, orthostatic BP measurements

  • Hemodynamic parametersOther

    Blood pressure measurements by "unattended BP" monitor over 5 min

  • Hemodynamic parametersOther

    Electrocardiogram

  • Assessment of compliance with antihypertensive treatments for treated participantsBehavioral

    EVALOBS scale and compliance questionnaire

  • Ambulatory 24 hours measurment of blood pressureOther

    For the first 100 patients willing to participate

  • 24 hours urinary collectionBiological

    For the first 100 patients willing to participate. For biobank constitution and measurement of microalbuminuria, creatininuria, osmolarity, natriuresis, kaliuresis, urea, proteinuria and urine dipstick

  • General questionnairesOther

    Collection of socio-demographic data such as age, level of education, profession, household income, smoking status, physical activity, perception of health, prematurity, height and weight at birth, family and personal history especially cardiovascular (history of stroke, myocardial infarction, heart failure, current pathologies, drugs, tobacco...)

  • Women specific questionnaireOther

    Women specific questionnaire

  • Women specific questionnaireBehavioral

    Women specific questionnaire

  • NYHA dyspnea questionnaireDiagnostic test

    Determination of NYHA class.

  • Anxiety questionnaireBehavioral

    Assessment of anxiety

  • Epworth Sleepiness ScaleBehavioral

    sleep quality assessment

  • A questionnaire on the "perception of the management of cardiovascular risk factors"Other

    Patient's evaluation of cardiovascular risk factors by the health system

  • A questionnaire on eating behaviorsBehavioral

    Assessment of eating behaviors

  • A questionnaire on eating habits to determine consumer profilesBehavioral

    Assessement of eating habit to create a consumer profile

  • A questionnaire on food supplements useDietary supplement

    Evaluation od food supplements intake

  • SARS-CoV-2 Infection QuestionnaireOther

    SARS-CoV-2 Infection Questionnaire

  • Instantaneous expired air analysisOther

    Carbon monoxyde analysis in expired air

  • Capillary samplingBiological

    Capillary sampling for pollutant analysis (Optional)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Indexed left ventricular mass measured by echocardiographyTime frame: Baseline
  2. Left ventricular volume measured by echocardiographyTime frame: Baseline
  3. Tissue doppler imaging e' wave measured by echocardiographyTime frame: Baseline
  4. Ratio E/e' measured by echocardiographyTime frame: Baseline
  5. Left atrial volume measured by echocardiographyTime frame: Baseline
  6. Pulmonary congestion evaluated by lung ultrasoundTime frame: Baseline
  7. Pulse wave velocity measured by Sphygmocor and Complior AnalyseTime frame: Baseline
  8. Carotid intima media thickness measured by echotrackingTime frame: Baseline
  9. Central blood pressureTime frame: Baseline

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • CHRU de Nancy

    Vandœuvre-lès-Nancy, Lorraine, France · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.